Core Laboratories Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 3/6
Core Laboratories has a total shareholder equity of $200.2M and total debt of $180.4M, which brings its debt-to-equity ratio to 90.2%. Its total assets and total liabilities are $593.6M and $393.5M respectively. Core Laboratories's EBIT is $48.8M making its interest coverage ratio 3.9. It has cash and short-term investments of $16.3M.
Wichtige Informationen
90.2%
Verhältnis von Schulden zu Eigenkapital
US$180.44m
Verschuldung
| Zinsdeckungsgrad | 3.9x |
| Bargeld | US$16.29m |
| Eigenkapital | US$200.15m |
| Gesamtverbindlichkeiten | US$393.47m |
| Gesamtvermögen | US$593.62m |
Jüngste Berichte zur Finanzlage
Keine Aktualisierungen
Recent updates
Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: CLB *'s short term assets ($227.9M) exceed its short term liabilities ($95.6M).
Langfristige Verbindlichkeiten: CLB *'s short term assets ($227.9M) do not cover its long term liabilities ($297.8M).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: CLB *'s net debt to equity ratio (82%) is considered high.
Schulden abbauen: CLB *'s debt to equity ratio has reduced from 155.1% to 90.2% over the past 5 years.
Schuldendeckung: CLB *'s debt is not well covered by operating cash flow (9.1%).
Zinsdeckung: CLB *'s interest payments on its debt are well covered by EBIT (3.9x coverage).